Johnson & Johnson Deferred Compensation Liability, Classified, Noncurrent
Johnson & Johnson (JNJ) had Deferred Compensation Liability, Classified, Noncurrent of $7.11 billion as of 2009-09-27, per its 10-Q filed 2009-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent · last filed 2009-11-04
- 2009-09-27: Deferred Compensation Liability, Classified, Noncurrent $7.11B.
- 2009-06-28: Deferred Compensation Liability, Classified, Noncurrent $7.37B.
- 2008-12-28: Deferred Compensation Liability, Classified, Noncurrent $7.79B.
| Period end | Deferred Compensation Liability, Classified, Noncurrent |
|---|---|
| 2009-09-27 | $7.11B 10-Q · filed 2009-11-04 |
| 2009-06-28 | $7.37B 10-Q · filed 2009-08-04 |
| 2008-12-28 | $7.79B 10-Q · filed 2009-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |